Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Evidence-based approach best for cancer management tools
Anaheim, Calif. - Topical imiquimod, systemic retinoids, and sentinellymph node biopsies are dermatologic tools that instigate promise and controversywhen discussing their role in managing basal cell carcinoma, squamous cellcarcinoma, and primary cutaneous melanoma, respectively.
Related Videos
Related Content
